ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,051.09
      0.00%
      US Tech 100
      21,191.20
      0.62%
      Dow Jones
      43,828.06
      -0.20%
      Brent Oil
      74.135
      0.00%
      Bitcoin
      101,353.14
      -0.10%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Impact Biomedical Inc (IBO) Quote

      Impact Biomedical Inc

      Impact Biomedical Inc (IBO)

      Universal Ibogaine Inc
      1.89
      -0.26
      (-12.09%)
      Closed December 14 4:00PM
      Delayed by 15 minutes
      1.99
      0.10
      (5.29%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.89
      Bid
      -
      Ask
      -
      Volume
      16,911
      1.93 Day's Range 2.40
      1.22 52 Week Range 3.25
      Previous Close
      2.15
      Open
      2.26
      Last Trade
      225
      @
      1.89
      Last Trade Time
      Average Volume (3m)
      69,785
      Financial Volume
      $ 35,883
      VWAP
      2.1219

      Ask ADVFN Intelligence (AI)

      IBO Latest News

      More News

      Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

      HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      November 19 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 04 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

      HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

      October 15 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 08 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

      HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      October 07 2024
      GlobeNewswire Inc.

      Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

      HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

      September 26 2024
      GlobeNewswire Inc.

      Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

      NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

      September 23 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 17 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

      NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) --  Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

      September 17 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.38-16.74008810572.272.451.58224132.20445223CS
      4-0.62-24.70119521912.513.251.58441322.66208322CS
      12-0.63-252.523.251.22697852.24050487CS
      26-1.11-3733.251.22810942.29713481CS
      52-1.11-3733.251.22810942.29713481CS
      156-1.11-3733.251.22810942.29713481CS
      260-1.11-3733.251.22810942.29713481CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      UMACUnusual Machines Inc
      $ 11.0811
      (25.21%)
      		6.89M
      TOONKartoon Studios Inc
      $ 0.62
      (21.59%)
      		1.08M
      GPUSHyperscale Data Inc
      $ 6.87
      (17.15%)
      		28.79k
      UAMYUnited States Antimony Corp
      $ 1.935
      (15.87%)
      		18.24M
      OPTTOcean Power Technologies Inc
      $ 0.3347
      (14.04%)
      		29.13M
      BURUNuburu Inc
      $ 0.33
      (-34.03%)
      		29.06M
      OSTXOS Therapies Incorporated
      $ 3.01
      (-32.51%)
      		347.69k
      AUMNGolden Minerals Co
      $ 0.1207
      (-18.50%)
      		1.31M
      CHROChannel Therapeutics Corporation
      $ 0.5851
      (-15.08%)
      		154.53k
      GROBrazil Potash Corp
      $ 9.70
      (-14.16%)
      		51.03k
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 0.841198
      (-7.56%)
      		947.99M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 30.70
      (7.87%)
      		103.68M
      NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
      $ 3.535
      (4.59%)
      		65.49M
      SPXSDirexion Daily S&P 500 Bear 3X Shares New
      $ 5.835
      (0.43%)
      		52.34M
      SENSSenseonics Holdings Inc
      $ 0.46
      (6.70%)
      		51.61M

      IBO Discussion

      View Posts
      Disquisition Disquisition 2 months ago
      INCREDIBLE DUMPING
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      IBO...BOTTOM BOUNCER
      👍️0
      rizah rizah 2 years ago
      All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.
      👍️0
      harry_brat harry_brat 2 years ago
      $IBO held on to its renowned capital market advisor

      UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.
      👍️0
      Blue_Digital_Media Blue_Digital_Media 3 years ago
      Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

      Watch now IBO for latest stock information.
      👍️0

      Your Recent History

      AMEX
      IBO
      Impact Biomedical
      Delayed Upgrade Clock